Healthcare & Life Sciences

Aveanna Healthcare's Heartways program earns a top national certification, signaling a major shift in managing America's costliest disease from home.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

A new walk-in lab with pediatric care opens in The Marketplace at Steamtown, marking a strategic move in retail health and enhancing local convenience.

Amid a surging aerospace market, StandardAero's upcoming earnings report is highly anticipated after a year of record growth and strategic expansion.

Health Canada grants conditional approval to BioMarin's VOXZOGO, the first drug in the country to target the genetic cause of achondroplasia.

Canadian giant Aurora Cannabis launches new high-THC flower and resin products in Australia and New Zealand, aiming to capture a larger share of the booming market.

Over 200 leaders gather to fight polarization, drawing lessons from Northern Ireland's peace process to model how to disagree without dehumanizing.

With FDA Priority Review, Takeda's oveporexton could be the first drug to target the root cause of narcolepsy, offering transformative hope for patients.

MapleTech's new Aspire Quick Start tool uses AI to cut underwriting from hours to minutes, offering a lifeline to an industry desperate for a turnaround.

A packed event for nannies in Georgetown reveals a major shift in childcare: caregivers are demanding professional recognition, community, and better standards.

An innovative agreement offers a streamlined path for assistants to become educators, directly tackling Ontario's critical child care workforce shortage.

A new AI Roleplay tool uses virtual avatars to simulate tough talks, aiming to scale soft skills training while reducing bias and mentor burnout.

A celebrated university chancellor joins a key strategic firm, a move that highlights a major shift in how higher education is tackling its biggest crises.

Global shocks are roiling fertilizer markets, creating a 'new normal' of price volatility. Can biological solutions offer farmers the stability they need?

FibroBiologics' Pete O'Heeron will speak at the H-SPAN summit, highlighting how cell therapy is driving a push for new healthspan legislation.

StorMagic appoints Scott Mann as Global SVP Sales, a strategic move to scale its channel and seize market share amid virtualization industry disruption.

Commercial real estate values rose for a sixth straight quarter, yet a stark divide between thriving industrial and lagging office sectors redefines the market.

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

As Milestone Pharma launches its novel, self-administered heart drug CARDAMYST, it hires a legal expert to navigate the high-stakes commercial rollout.

The firm's $0.47 Q4 dividend is backed by record income and improving credit quality, offering a compelling case for income and global investors.